JRC Publications Repository

JRC Publications Repository > Joint Research Centre > Institute for Transuranium Elements >

Please use this identifier to cite or link to this item: http://publications.jrc.ec.europa.eu/repository/handle/111111111/24376

Title: Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model
Authors: GUSTAFSSON Anna
BAECK Tom
ELGQVIST Joergen
JACOBSSON Lars
HULTBORN Ragnar
ALBERTSSON Per
MORGENSTERN Alfred
BRUCHERTSEIFER Frank
JENSEN Holger
LINDEGREN Sture
Citation: NUCLEAR MEDICINE AND BIOLOGY vol. 39 no. 1 p. 15-22
Publisher: ELSEVIER SCIENCE INC
Publication Year: 2012
JRC Publication N°: JRC66054
ISSN: 0969-8051
URI: www.elsevier.com/locate/nucmedbio
http://publications.jrc.ec.europa.eu/repository/handle/111111111/24376
DOI: 10.1016/j.nucmedbio.2011.07.003
Type: Articles in Journals
Appears in Collections:Institute for Transuranium Elements

Files in This Item:

There are no files associated with this item.

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top